Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
About this item
Full title
Author / Creator
Daud, Adil I. , Loo, Kimberly , Pauli, Mariela L. , Sanchez-Rodriguez, Robert , Sandoval, Priscila Munoz , Taravati, Keyon , Tsai, Katy , Nosrati, Adi , Nardo, Lorenzo , Alvarado, Michael D. , Algazi, Alain P. , Pampaloni, Miguel H. , Lobach, Iryna V. , Hwang, Jimmy , Pierce, Robert H. , Gratz, Iris K. , Krummel, Matthew F. and Rosenblum, Michael D.
Publisher
United States: American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
United States: American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
Immune checkpoint blockade is revolutionizing therapy for advanced cancer, but many patients do not respond to treatment. The identification of robust biomarkers that predict clinical response to specific checkpoint inhibitors is critical in order to stratify patients and to rationally select combinations in the context of an expanding array of the...
Alternative Titles
Full title
Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
Authors, Artists and Contributors
Author / Creator
Loo, Kimberly
Pauli, Mariela L.
Sanchez-Rodriguez, Robert
Sandoval, Priscila Munoz
Taravati, Keyon
Tsai, Katy
Nosrati, Adi
Nardo, Lorenzo
Alvarado, Michael D.
Algazi, Alain P.
Pampaloni, Miguel H.
Lobach, Iryna V.
Hwang, Jimmy
Pierce, Robert H.
Gratz, Iris K.
Krummel, Matthew F.
Rosenblum, Michael D.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5004965
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5004965
Other Identifiers
ISSN
0021-9738
E-ISSN
1558-8238
DOI
10.1172/JCI87324
